Jeffrey Stein Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jeffrey Stein.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jeffrey Stein. Jeffrey Stein is a Director in Paratek Pharmaceuticals, Inc. ($PRTK) and a President and CEO in Trius Therapeutics Inc ($TSRX) and a President & CEO in Cidara Therapeutics, Inc. ($CDTX) and a Director in IDEAYA Biosciences, Inc. ($IDYA).
Address: C/O TRIUS THERAPEUTICS, INC. 6310 NANCY RIDGE DRIVE, SUITE 101 SAN DIEGO 92121 CA
Companies in which Jeffrey Stein is an Insider
Cidara Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Jeffrey Stein: President & CEO
Holdings: 361,878 shares
Current Value: $3,474,029
Latest Transaction: Apr 05 2021
$CDTX Market Capitalization: $167.56M
$CDTX Previous Close: $9.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IDEAYA Biosciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jeffrey Stein: Director
Holdings: 0 shares
Latest Transaction: Jun 18 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Paratek Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jeffrey Stein: Director
Holdings: 35,625 shares
Current Value: $543,281
Latest Transaction: Feb 22 2021
$PRTK Market Capitalization: $346.19M
$PRTK Previous Close: $15.25
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Trius Therapeutics Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jeffrey Stein: President and CEO
Holdings: 171,995 shares
Latest Transaction: Mar 11 2013
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Jeffrey Stein
Sentiment: All, CDTX, IDYA, PRTK, TSRX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 05 2021 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Grant | A | 0.00 | 10,000 | 0 | 361,878 | 351.9 K to 361.9 K (+2.84 %) |
| Mar 19 2021 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Option Exercise | A | 2.55 | 525,000 | 1,338,750 | 525,000 | |
| Mar 19 2021 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Option Exercise | A | 2.55 | 525,000 | 1,338,750 | 525,000 | |
| Feb 22 2021 | PRTK | Paratek Pharmaceut ... | Stein Jeffrey | Director | Option Exercise | A | 7.61 | 7,000 | 53,270 | 7,000 | |
| Feb 22 2021 | PRTK | Paratek Pharmaceut ... | Stein Jeffrey | Director | Grant | A | 0.00 | 9,000 | 0 | 35,625 | 26.6 K to 35.6 K (+33.80 %) |
| Nov 12 2020 | CDTX | Cidara Therapeutic ... | Stein Jeffrey | President & CEO | Buy | P | 2.00 | 50,000 | 100,015 | 347,878 | 297.9 K to 347.9 K (+16.79 %) |
| Jun 18 2020 | IDYA | IDEAYA Biosciences ... | Stein Jeffrey | Director | Option Exercise | A | 12.84 | 11,000 | 141,240 | 11,000 |